A question that I have about the stock price in the coming weeks after asco concerns what harvey berger himself stated. Correct me if im wrong, but didnt h.b. Imply late last year, that the company could potentially have 2 fda approved drugs by the end of 2012? If thats the case, shouldn't the company be filing the nda for ponatnib soon, for a possible fda approval by the end of the year? I dont see any hold ups that have taken place since his statements on approvals. Shouldnt we be expecting the filing soon? In my opinion, that is what we would need for the next leg up, and not just positive updates.
